The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Prevalence of Hematopoietic Cell Transplant Survivors in the United States
Open accessAbstract
Advances in hematopoietic cell transplantation (HCT) have led to an increasing number of transplant survivors. To adequately support their healthcare needs, there is a need to know the prevalence of HCT survivors. We used data on 170,628 recipients of autologous and allogeneic HCT reported to the Center for International Blood and Marrow Transplant Research from 1968 to 2009 to estimate the current and future number of HCT survivors in the United States. Stacked cohort simulation models were used to estimate the number of HCT survivors in the United States in 2009 and to make projections for HCT survivors by the year 2030. There were 108,900 (range, 100,500 to 115,200) HCT survivors in the United States in 2009. This included 67,000 autologous HCT and 41,900 allogeneic HCT survivors. The number of HCT survivors is estimated to increase by 2.5 times by the year 2020 (242,000 survivors) and 5 times by the year 2030 (502,000 survivors). By 2030, the age at transplant will be < 18 years for 14% of all survivors (n = 64,000), 18 to 59 years for 61% survivors (n = 276,000), and 60 years and older for 25% of survivors (n = 113,000). In coming decades, a large number of individuals will be HCT survivors. Transplant center providers, hematologists, oncologists, primary care physicians, and other specialty providers will need to be familiar with the unique and complex health issues faced by this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004383 · Cited by 1,493
Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation
Socié, G., Stone, J. V., Wingard, J. R., Weisdorf, D., Henslee-Downey, P. J., Bredeson, C., Cahn, J.-Y., Passweg, J. R., Rowlings, P. A., Schouten, H. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410103 · Cited by 698
Self-citationde Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., Forsythe, L., Scoppa, S., Hachey, M., & Rowland, J. H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1356 · Cited by 670 · cited 1×
“DISCUSSION The cancer survivor population in the United States is expected to grow to 18 million by 2022 [19], and, based on”
BackgroundLong-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
Wingard, J. R., Majhail, N. S., Brazauskas, R., Wang, Z., Sobocinski, K. A., Jacobsohn, D., Sorror, M. L., Horowitz, M. M., Bolwell, B., Rizzo, J. D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7212 · Cited by 632
Self-citationBhatia, S., Francisco, L., Carter, A., Sun, C.-L., Baker, K. S., Gurney, J. G., McGlave, P. B., Nademanee, A., O'Donnell, M., Ramsay, N. K. C., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082933 · Cited by 540
Majhail, Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20120032 · Cited by 509
Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
Martin, P. J., Counts, G. W., Appelbaum, F. R., Lee, S. J., Sanders, J. E., Deeg, H. J., Flowers, M. E. D., Syrjala, K. L., Hansen, J. A., Storb, R. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6693 · Cited by 366
Self-citationMajhail, N. S., Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2011.12.519 · Cited by 363
Self-citationMajhail, N. S., Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.5 · Cited by 248
Self-citationBhatia, S., Robison, L. L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K. S., Fung, H., Gurney, J. G., McGlave, P. B., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0035 · Cited by 242
Horan, J. T., Logan, B. R., Agovi-Johnson, M.-A., Lazarus, H. M., Bacigalupo, A. A., Ballen, K. K., Bredeson, C. N., Carabasi, M. H., Gupta, V., Hale, G. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5001 · Cited by 203
Self-citationSurviving the cure: long term followup of hematopoietic cell transplant recipients
Majhail, N. S., & Rizzo, J. D. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.258 · Cited by 159
Self-citationGoldman, J. M., Majhail, N. S., Klein, J. P., Wang, Z., Sobocinski, K. A., Arora, M., Horowitz, M. M., & Rizzo, J. D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7757 · Cited by 137
Self-citationHow I treat late effects in adults after allogeneic stem cell transplantation
Savani, B. N., Griffith, M. L., Jagasia, S. M., & Lee, S. J. (2010) · Blood · doi:10.1182/blood-2010-10-263095 · Cited by 121
Self-citationSun, C., Kersey, J. H., Francisco, L., Armenian, S. H., Baker, K. S., Weisdorf, D. J., Forman, S. J., & Bhatia, R. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.04.002 · Cited by 121
Delivering Care to Long-Term Adult Survivors of Hematopoietic Cell Transplantation
Syrjala, K. L., Martin, P. J., & Lee, S. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.3038 · Cited by 117
Self-citationMcCarthy, P. L., Hahn, T., Hassebroek, A. M., Bredeson, C., Gajewski, J., Hale, G. A., Isola, L. M., Lazarus, H. M., Lee, S. J., LeMaistre, C. F., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.04.027 · Cited by 113
Self-citationSecondary cancers following allogeneic haematopoietic cell transplantation in adults
Majhail, N. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08756.x · Cited by 72
Self-citationMajhail, N. S., Bajorunaite, R., Lazarus, H. M., Wang, Z., Klein, J. P., Zhang, M., & Rizzo, J. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07798.x · Cited by 61
Self-citationImpending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce
Gajewski, J., LeMaistre, C. F., Silver, S. M., Lill, M., Selby, G. B., Horowitz, M. M., Rizzo, J. D., Heslop, H. E., Anasetti, C., & Maziarz, R. T. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.08.022 · Cited by 59
Self-citationDenzen, E. M., Majhail, N. S., Ferguson, S. S., Anasetti, C., Bracey, A., Burns, L. J., Champlin, R., Chell, J. W., Leather, H. L., Lill, M., et al. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.10.005 · Cited by 35
Self-citation
Cited by
Syrjala, K. L., Yi, J. C., Artherholt, S. B., Romano, J. M., Crouch, M.-L., Fiscalini, A. S., Hegel, M. T., Flowers, M. E. D., Martin, P. J., & Leisenring, W. M. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-018-0693-9 · Cited by 76
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations
Baumrin, E., Loren, A. W., Falk, S. J., Mays, J. W., & Cowen, E. W. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.12.024 · Cited by 59
Retracted
Metadata
- Authors
- Majhail, N. S., Tao, L., Bredeson, C., Davies, S., Dehn, J., Gajewski, J. L., Hahn, T., Jakubowski, A., Joffe, S., Lazarus, H. M., Parsons, S. K., Robien, K., Lee, S. J., & Kuntz, K. M.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 19
- Issue
- 10
- Pages
- 1498-1501
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2109195714
- Cited by
- 258
- References
- 23
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.